Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-068059
Filing Date
2025-05-09
Accepted
2025-05-09 16:21:16
Documents
110
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q btmd-20250331.htm   iXBRL 10-Q 2800307
2 EX-10.1 btmd-ex10_1.htm EX-10.1 32176
3 EX-31.1 btmd-ex31_1.htm EX-31.1 17382
4 EX-31.2 btmd-ex31_2.htm EX-31.2 17756
5 EX-32.1 btmd-ex32_1.htm EX-32.1 10171
6 EX-32.2 btmd-ex32_2.htm EX-32.2 10429
7 GRAPHIC img171499526_0.jpg GRAPHIC 12770
  Complete submission text file 0000950170-25-068059.txt   14261404

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20250331.xsd EX-101.SCH 1867712
113 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20250331_htm.xml XML 3089207
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40128 | Film No.: 25930750
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)